BSc (Hons), MBBS (Hons) MEd MRCP
Novo Nordisk Clinical Research Training Fellow (2016-2019)
- Project: Using Multi-Parametric Magnetic Resonance Techniques to determine the severity and response to treatment of liver fibrosis, inflammation, steatosis and iron in patients with type 2 diabetes and non-alcoholic fatty liver disease
Ahmad was awarded a Novo Nordisk Clinical Research Training Fellowship focused on non-alcoholic fatty liver disease (NAFLD), which is becoming the most common cause of chronic liver disease worldwide and affects up to 70% of patients with type 2 diabetes. He established a clinical trial to investigate the utility of GLP-1 agonists as novel therapeutic agents for patients with NAFLD. Additionally, through this and related clinical studies, he also investigated the use of various biomarkers as novel non-invasive diagnostic tools with which to diagnose and stage NAFLD and to access treatment response.
Ahmad returned to his clinical career full time in February 2019, whilst writing his DPhil thesis. He is currently a Specialist Registrar in Diabetes, Endocrinology and Metabolism working in the Imperial College North-West Thames NHS Deanery Rotation. He is continuing to develop his sub-specialty interest in obesity and fatty liver disease. He will be completing his post-graduate clinical training during which time he will work on progressing to the next stage of his joint academic and clinical career.
SGLT2 inhibition does not reduce hepatic steatosis in overweight, insulin resistant patients without type 2 diabetes
Marjot T. et al, (2019), JOURNAL OF HEPATOLOGY, 70, E68 - E68
The effect of metformin on hepatic fatty acid partitioning; an investigation using human in vivo and in vitro models
Green C. et al, (2019), JOURNAL OF HEPATOLOGY, 70, E794 - E795
Mapping tissue water T1 in the liver using the MOLLI T1 method in the presence of fat, iron and B0 inhomogeneity.
Mozes FE. et al, (2019), NMR Biomed, 32
A multidisciplinary approach to the management of NAFLD is associated with improvement in markers of liver and cardio-metabolic health
Moolla A. et al, (2019), Frontline Gastroenterology
Liver biochemical abnormalities in Turner syndrome: A comprehensive characterization of an adult population.
Calanchini M. et al, (2018), Clin Endocrinol (Oxf), 89, 667 - 676